Slide 1: Zicom FY2011 Results Briefing
For personal use only ZICOM FY2011 RESULTS BRIEFING 5 SEPTEMBER 2011 Your Partner in Progress
Slide 2: Main Activities
Main Activities For personal use only BUSINESS ACTIVITIES Specialist equipment manufacturer with core expertise in hydraulic, flow control & precision engineering BUSINESS SEGMENTS: Offshore marine, oil and gas machinery Construction equipment Precision engineering & automation Industrial and mobile
Slide 3: Our Direct Presence
Our Direct Presence Indonesia Thailand China Australia For personal use only Batam, Indonesia Chonburi, Thailand Huzhou, China Brisbane, Australia Singapore HO Singapore Singapore Singapore
Slide 4: Group Organization Chart
Group Organization Chart For personal use only Zicom Group Limited. Australia. ASX Listed. Cesco Australia Ltd. Zicom Holdings Pte Ltd. Australia. 100%. Singapore. 100%. Concrete mixers. Investment Holding. Hangzhou Cesco Foundation Associates Curiox Biosystems Pte Orion Systems Sys-Mac Automation Z
Slide 5: 2011 Key Financial Performance
2011 Key Financial Performance For personal use only Net Profit 39.0% to S$14m from S$10m EPS 37.3% to Sgp 6.62 cts (Aust 5.2 cts) Dividend per share 17.6% from Aust 0.85 cts to 1 cts ROE 3.1% from 16.4% to 19.5% NTA per share Sgp 4.55 cts from 28.21 to 32.76 cts Net Working Capital S$7.42m from S$3
Slide 6: Consolidated Revenue Vs. NPAT Trend
ZICOM GROUP LTD Consolidated Revenue Vs. NPAT Trend For personal use only S#039;million 160 147 18 Millions Millions 135 16 140 127 14.5 120 14 108 14.1 11.8 12 100 95 9.5 10.1 Net Profit Revenue 10 80 7.8 10.0 9.6 8.7 8 60 45 7.3 6 40 2.8 4 20 2.7 2 0 0 2006 2007 2008 2009 2010 2011 Revenue NPAT Norma
Slide 7: Revenue by Segment
Revenue by Segment For personal use only FY2011 FY2010
Slide 8: Consistent Earnings Growth
Consistent Earnings Growth For personal use only Net Profit (S$m) EPS (Singapore Cents)
Slide 9: ROE & Dividend
For personal use only ROE & Dividend
Slide 10: Shareholder Spread
For personal use only Shareholder Spread
Slide 11: Business Outlook
For personal use only Business Outlook
Slide 12: Offshore Marine
Offshore Marine For personal use only Review Slack in ship building orders for offshore vessels post GFC Outlook Slackened demand to continue into at least first half FY12 Enquiries resurged recently, momentum likely in the next 12 to 18 months. Demand for offshore structures picked up. Forayed into
Slide 13: Oil & Gas
Oil & Gas For personal use only Review Delays in projects due to slow engineering approvals Outlook Repositioned into EPC 18 months ago. Since then secured orders of S$28m, S$20m for delivery 2012/2013. Strong prospects to increase orders in coming half year. Engineering and management capabilities
Slide 14: Construction
Construction For personal use only Concrete Mixer Vibro-Hammer Largest Vibro SE Asia Conventional Biogas Generator Review Increased by 28.9%. Construction consolidated in Australia, Asian demand increased Australian business expanded to sales/rental of foundation equipment, gas driven generators and
Slide 15: Precision Engineering & Automation
Precision Engineering & Automation For personal use only Review Increase in production capacity enables us to cope with increase in automation services and contract manufacturing. Lower margin contract manufacturing, softened US$ impacted results. Marked increase in ‘design and build’ automation pro
Slide 16: Industrial & Mobile Hydraulics
Industrial & Mobile Hydraulics For personal use only Review Sector made up of supply of hydraulic system drives and other ancillary products, as supporting services to customers, generally flat in performance. Outlook Existing revenue components remain stable and flat. Gas driven generators and soon
Slide 17: Investment in Disruptive Technologies: Surgical Robot
Investment in Disruptive Technologies For personal use only Surgical Robot Secured regulatory approvals from authorities in Singapore, Australia, the European Union and USA. Still undergoing clinical evaluation in Singapore, Australia, Taiwan and USA. Marketing gestation is dependent on clinical acc
Slide 18: Investment in Disruptive Technologies: Drug Discovery Bio-Instrumentation
Investment in Disruptive Technologies For personal use only Drug Discovery Bio-Instrumentation Prototypes trialed, evaluated and approved by USA world leader in protein therapeutic medicine and Japan’s largest pharmaceutical company achieving better accuracy and cost savings in drug discovery. Sold
Slide 19: Investment in Disruptive Technologies: Thermal Bonder
Investment in Disruptive Technologies For personal use only Thermal Bonder –Melt & Touch Down Thermal-bonds fine-pitch flip chips of less than 40 micron nodes, a first of its kind break-through for bonding of high powered chips born out of nanotechnology Prototype trialed, evaluated and accepted by
Slide 20: Thank You
For personal use only Thank You & Have a Nice Day!